Skip to search formSkip to main contentSkip to account menu

teriflunomide

Known as: Teriflunomida, (Z)-2-Cyano-alpha,alpha,alpha-trifluoro-3-hydroxy-P-crotonotoluidide, Teriflunomidum 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
P001 Regulator of Oligodendrocyte Maturation, Mir-219, a Potential Biomarker for MS Dr. Ilona B Bruinsma, PhD1, Dr. Marie van… 
2018
2018
BackgroundThe likelihood to help or harm (LHH) is an absolute measure of the benefit versus risk profile of a medication, which… 
2017
2017
Objective: One of the challenges of the last years is to take care of patients with complex treatments, including new drugs… 
2016
2016
Stwardnienie rozsiane cześciej wystepuje u kobiet, a szczyt zachorowan przypada na wiek rozrodczy. Dlatego zagadnienie ciązy w… 
Review
2016
Review
2016
Purpose of Review:This article provides an evidence-based approach to the management of patients with early relapsing multiple… 
Review
2013
Review
2013
Interferon beta and glatiramer acetate are still considered to be the first-line therapeutics for treatment of relapsing forms of… 
Review
2013
Review
2013
ABSTRACT Multiple sclerosis (MS) is a complex disease that affects the central nervous system. It is believed to be an immune… 
2013
2013
▼ Lefl unomide is a disease-modifying antirheumatic drug. The purpose of this study was to evaluate the bioequivalence of a test… 
2012
2012
Objective: To assess the effect of repeated doses of teriflunomide on the pharmacokinetics (PK) of bupropion, a probe substrate… 
2010
2010
The present invention, for the preparation of a medicament for use in the treatment of multiple sclerosis, associated with the…